Additionally, CCR6 expressed by CD4+ T cells inhibits the function of FOXP3 and promotes the differentiation of CD4+ T cells into Th17 cells, leading to an imbalance in the Th17/Tregs ratio and accelerating the development and progression of RA [31]. This evidence concerns the gene CCR6 and rheumatoid arthritis.